The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Antibiotic failure: Beyond antimicrobial resistance
Open accessAbstract
Despite significant progress in antibiotic discovery, millions of lives are lost annually to infections. Surprisingly, the failure of antimicrobial treatments to effectively eliminate pathogens frequently cannot be attributed to genetically-encoded antibiotic resistance. This review aims to shed light on the fundamental mechanisms contributing to clinical scenarios where antimicrobial therapies are ineffective (i.e., antibiotic failure), emphasizing critical factors impacting this under-recognized issue. Explored aspects include biofilm formation and sepsis, as well as the underlying microbiome. Therapeutic strategies beyond antibiotics, are examined to address the dimensions and resolution of antibiotic failure, actively contributing to this persistent but escalating crisis. We discuss the clinical relevance of antibiotic failure beyond resistance, limited availability of therapies, potential of new antibiotics to be ineffective, and the urgent need for novel anti-infectives or host-directed therapies directly addressing antibiotic failure. Particularly noteworthy is multidrug adaptive resistance in biofilms that represent 65 % of infections, due to the lack of approved therapies. Sepsis, responsible for 19.7 % of all deaths (as well as severe COVID-19 deaths), is a further manifestation of this issue, since antibiotics are the primary frontline therapy, and yet 23 % of patients succumb to this condition.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Murray, C. J. L., Ikuta, K. S., Sharara, F., Swetschinski, L., Robles Aguilar, G., Gray, A., Han, C., Bisignano, C., Rao, P., Wool, E., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02724-0 · Cited by 16,316
Rudd, K. E., Johnson, S. C., Agesa, K. M., Shackelford, K. A., Tsoi, D., Kievlan, D. R., Colombara, D. V., Ikuta, K. S., Kissoon, N., Finfer, S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32989-7 · Cited by 7,971
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
Understanding biofilm resistance to antibacterial agents
Davies, D. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1008 · Cited by 2,781
Antibiotics: past, present and future
Hutchings, M. I., Truman, A. W., & Wilkinson, B. (2019) · Current Opinion in Microbiology · doi:10.1016/j.mib.2019.10.008 · Cited by 2,370
Antimicrobial Resistance: Implications and Costs
Dadgostar, P. (2019) · Infection and Drug Resistance · doi:10.2147/idr.s234610 · Cited by 2,024
Targeting microbial biofilms: current and prospective therapeutic strategies
Koo, H., Allan, R. N., Howlin, R. P., Stoodley, P., & Hall-Stoodley, L. (2017) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.99 · Cited by 1,800
Antibiotics versus biofilm: an emerging battleground in microbial communities
Sharma, D., Misba, L., & Khan, A. U. (2019) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-019-0533-3 · Cited by 1,553
Antimicrobial host defence peptides: functions and clinical potential
Mookherjee, N., Anderson, M. A., Haagsman, H. P., & Davidson, D. J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0058-8 · Cited by 1,502
Nanotechnology as a therapeutic tool to combat microbial resistance
Pelgrift, R. Y., & Friedman, A. J. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.07.011 · Cited by 1,432
The biofilm life cycle: expanding the conceptual model of biofilm formation
Sauer, K., Stoodley, P., Goeres, D. M., Hall-Stoodley, L., Burmølle, M., Stewart, P. S., & Bjarnsholt, T. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00767-0 · Cited by 1,404
Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention
Khatoon, Z., McTiernan, C. D., Suuronen, E. J., Mah, T.-F., & Alarcon, E. I. (2018) · Heliyon · doi:10.1016/j.heliyon.2018.e01067 · Cited by 1,187
TREATMENT OF STAPHYLOCOCCAL INFECTIONS WITH PENICILLIN BY INTERMITTENT STERILISATION
Bigger, J. (1944) · The Lancet · doi:10.1016/s0140-6736(00)74210-3 · Cited by 1,178
Theriot, C. M., Koenigsknecht, M. J., Carlson, P. E., Hatton, G. E., Nelson, A. M., Li, B., Huffnagle, G. B., Z. Li, J., & Young, V. B. (2014) · Nature Communications · doi:10.1038/ncomms4114 · Cited by 974
The immunology of host defence peptides: beyond antimicrobial activity
Hancock, R. E. W., Haney, E. F., & Gill, E. E. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.29 · Cited by 945
Self-citationImpact of antibiotics on the human microbiome and consequences for host health
Patangia, D. V., Anthony Ryan, C., Dempsey, E., Paul Ross, R., & Stanton, C. (2022) · MicrobiologyOpen · doi:10.1002/mbo3.1260 · Cited by 754
Modulating immunity as a therapy for bacterial infections
Hancock, R. E. W., Nijnik, A., & Philpott, D. J. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2745 · Cited by 535
Self-citationBroad-Spectrum Anti-biofilm Peptide That Targets a Cellular Stress Response
de la Fuente-Núñez, C., Reffuveille, F., Haney, E. F., Straus, S. K., & Hancock, R. E. W. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004152 · Cited by 521
Self-citationAntimicrobial Peptides and Their Therapeutic Potential for Bacterial Skin Infections and Wounds
Pfalzgraff, A., Brandenburg, K., & Weindl, G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00281 · Cited by 481
Common Severe Infections in Chronic Granulomatous Disease
Marciano, B. E., Spalding, C., Fitzgerald, A., Mann, D., Brown, T., Osgood, S., Yockey, L., Darnell, D. N., Barnhart, L., Daub, J., et al. (2015) · Clinical Infectious Diseases · doi:10.1093/cid/ciu1154 · Cited by 423
Discovery of antimicrobial peptides in the global microbiome with machine learning
Santos-Júnior, C. D., Torres, M. D. T., Duan, Y., Rodríguez del Río, Á., Schmidt, T. S. B., Chong, H., Fullam, A., Kuhn, M., Zhu, C., Houseman, A., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.013 · Cited by 419
Self-citationCharacteristics and outcomes of culture-negative versus culture-positive severe sepsis.
Phua, J., Ngerng, W. J., See, K. C., Tay, C. K., Kiong, T., Lim, H. F., Chew, M. Y., Yip, H. S., Tan, A., Khalizah, H. J., et al. (2013) · Critical Care · doi:10.1186/cc12896 · Cited by 382
The role of the microbiota in infectious diseases
Libertucci, J., & Young, V. B. (2018) · Nature Microbiology · doi:10.1038/s41564-018-0278-4 · Cited by 357
Sweeney, T. E., Shidham, A., Wong, H. R., & Khatri, P. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa5993 · Cited by 332
Economic significance of biofilms: a multidisciplinary and cross-sectoral challenge
Cámara, M., Green, W., MacPhee, C. E., Rakowska, P. D., Raval, R., Richardson, M. C., Slater-Jefferies, J., Steventon, K., & Webb, J. S. (2022) · npj Biofilms and Microbiomes · doi:10.1038/s41522-022-00306-y · Cited by 332
Quorum Sensing: A Prospective Therapeutic Target for Bacterial Diseases
Jiang, Q., Chen, J., Yang, C., Yin, Y., & Kang, Y. (2019) · BioMed Research International · doi:10.1155/2019/2015978 · Cited by 327
Leveraging artificial intelligence in the fight against infectious diseases
Wong, F., de la Fuente-Nunez, C., & Collins, J. J. (2023) · Science · doi:10.1126/science.adh1114 · Cited by 301
Self-citationMicrotiter plate assays to assess antibiofilm activity against bacteria
Haney, E. F., Trimble, M. J., & Hancock, R. E. W. (2021) · Nature Protocols · doi:10.1038/s41596-021-00515-3 · Cited by 295
Self-citationA Broad-Spectrum Antibiofilm Peptide Enhances Antibiotic Action against Bacterial Biofilms
Reffuveille, F., de la Fuente-Núñez, C., Mansour, S., & Hancock, R. E. W. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03163-14 · Cited by 293
Self-citationAntibiofilm activity of host defence peptides: complexity provides opportunities
Hancock, R. E. W., Alford, M. A., & Haney, E. F. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00585-w · Cited by 270
Self-citationPatisiran, an RNAi Therapeutic for the Treatment of Hereditary Transthyretin-Mediated Amyloidosis
Kristen, A. V., Ajroud-Driss, S., Conceição, I., Gorevic, P., Kyriakides, T., & Obici, L. (2019) · Neurodegenerative Disease Management · doi:10.2217/nmt-2018-0033 · Cited by 268
Yu, K., Lo, J. C. Y., Yan, M., Yang, X., Brooks, D. E., Hancock, R. E. W., Lange, D., & Kizhakkedathu, J. N. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.047 · Cited by 256
Self-citationA Molecular Biomarker to Diagnose Community-acquired Pneumonia on Intensive Care Unit Admission
Scicluna, B. P., Klein Klouwenberg, P. M. C., van Vught, L. A., Wiewel, M. A., Ong, D. S. Y., Zwinderman, A. H., Franitza, M., Toliat, M. R., Nürnberg, P., Hoogendijk, A. J., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201502-0355oc · Cited by 247
Howlin, R. P., Brayford, M. J., Webb, J. S., Cooper, J. J., Aiken, S. S., & Stoodley, P. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.03676-14 · Cited by 245
Overview of Infections in the Immunocompromised Host
Dropulic, L. K., & Lederman, H. M. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.dmih2-0026-2016 · Cited by 233
Tegegne, B. A., & Kebede, B. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09725 · Cited by 232
Phages and their potential to modulate the microbiome and immunity
Federici, S., Nobs, S. P., & Elinav, E. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00532-4 · Cited by 222
Antibiofilm Peptides: Potential as Broad-Spectrum Agents
Pletzer, D., & Hancock, R. E. W. (2016) · Journal of Bacteriology · doi:10.1128/jb.00017-16 · Cited by 220
Self-citationMcHugh, L., Seldon, T. A., Brandon, R. A., Kirk, J. T., Rapisarda, A., Sutherland, A. J., Presneill, J. J., Venter, D. J., Lipman, J., Thomas, M. R., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001916 · Cited by 213
Pletzer, D., Mansour, S. C., & Hancock, R. E. W. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007084 · Cited by 211
Self-citationHeterogeneity in sepsis: new biological evidence with clinical applications
Leligdowicz, A., & Matthay, M. A. (2019) · Critical Care · doi:10.1186/s13054-019-2372-2 · Cited by 209
Baghela, A., Pena, O. M., Lee, A. H., Baquir, B., Falsafi, R., An, A., Farmer, S. W., Hurlburt, A., Mondragon-Cardona, A., Rivera, J. D., et al. (2022) · eBioMedicine · doi:10.1016/j.ebiom.2021.103776 · Cited by 209
Self-citationAdvances in the Sensing and Treatment of Wound Biofilms
Darvishi, S., Tavakoli, S., Kharaziha, M., Girault, H. H., Kaminski, C. F., & Mela, I. (2022) · Angewandte Chemie International Edition · doi:10.1002/anie.202112218 · Cited by 199
Optimizing antibiotic therapies to reduce the risk of bacterial resistance
Bassetti, S., Tschudin-Sutter, S., Egli, A., & Osthoff, M. (2022) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2022.01.029 · Cited by 196
Sepsis and Septic Shock: Current Treatment Strategies and New Approaches
Halici, Z., Cadirci, E., Polat, G., & Ugan, R. A. (2019) · The Eurasian Journal of Medicine · doi:10.5152/eurasianjmed.2017.17062 · Cited by 192
Molecular de-extinction of ancient antimicrobial peptides enabled by machine learning
Maasch, J. R. M. A., Torres, M. D. T., Melo, M. C. R., & de la Fuente‐Núñez, C. (2023) · Cell Host & Microbe · doi:10.1016/j.chom.2023.07.001 · Cited by 180
DiGiandomenico, A., Warrener, P., Hamilton, M., Guillard, S., Ravn, P., Minter, R., Camara, M. M., Venkatraman, V., MacGill, R. S., Lin, J., et al. (2012) · Journal of Experimental Medicine · doi:10.1084/jem.20120033 · Cited by 174
Im, Y., Kang, D., Ko, R.-E., Lee, Y. J., Lim, S. Y., Park, S., Na, S. J., Chung, C. R., Park, M. H., Oh, D. K., et al. (2022) · Critical Care · doi:10.1186/s13054-021-03883-0 · Cited by 173
Probiotics in Helicobacter pylori eradication therapy: A systematic review and meta-analysis
Zhang, M.-M. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i14.4345 · Cited by 167
Deep generative models for peptide design
Wan, F., Kontogiorgos-Heintz, D., & de la Fuente‐Núñez, C. (2022) · Digital Discovery · doi:10.1039/d1dd00024a · Cited by 166
Goodman, C., Keating, G., Georgousopoulou, E., Hespe, C., & Levett, K. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-043054 · Cited by 163
Anti-virulence therapeutic strategies against bacterial infections: recent advances
Dehbanipour, R., & Ghalavand, Z. (2022) · GERMS · doi:10.18683/germs.2022.1328 · Cited by 162
Timing of antibiotic therapy in the ICU
Kollef, M. H., Shorr, A. F., Bassetti, M., Timsit, J.-F., Micek, S. T., Michelson, A. P., & Garnacho-Montero, J. (2021) · Critical Care · doi:10.1186/s13054-021-03787-z · Cited by 161
Adaptive resistance to antibiotics in bacteria: a systems biology perspective
Sandoval‐Motta, S., & Aldana, M. (2016) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.1335 · Cited by 158
Pena, O. M., Hancock, D. G., Lyle, N. H., Linder, A., Russell, J. A., Xia, J., Fjell, C. D., Boyd, J. H., & Hancock, R. E. W. (2014) · EBioMedicine · doi:10.1016/j.ebiom.2014.10.003 · Cited by 153
Self-citationTsalik, E. L., Jones, D. C., Nicholson, B. P., Waring, L. J., Liesenfeld, O., Park, L. P., Glickman, S. W., Caram, L. B., Langley, R. J., van Velkinburgh, J. C., et al. (2009) · Journal of Clinical Microbiology · doi:10.1128/jcm.01447-09 · Cited by 141
Totsika, M., Kostakioti, M., Hannan, T. J., Upton, M., Beatson, S. A., Janetka, J. W., Hultgren, S. J., & Schembri, M. A. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit245 · Cited by 139
Viral-Bacterial Co-infections in the Cystic Fibrosis Respiratory Tract
Kiedrowski, M. R., & Bomberger, J. M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03067 · Cited by 136
Monoclonal antibody-based therapies for bacterial infections
Motley, M. P., Banerjee, K., & Fries, B. C. (2019) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000539 · Cited by 134
An approach to antibiotic treatment in patients with sepsis
Martínez, M. L., Plata-Menchaca, E. P., Ruiz‐Rodríguez, J. C., & Ferrer, R. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2020.01.47 · Cited by 134
Immunostimulants for preventing respiratory tract infection in children
Del-Rio-Navarro, B. E., Espinosa-Rosales, F. J., Flenady, V., & Sienra‐Monge, J. J. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004974.pub2 · Cited by 130
Barnhill, A. E., Brewer, M. T., & Carlson, S. A. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00678-12 · Cited by 126
Infections due to dysregulated immunity: an emerging complication of cancer immunotherapy
Morelli, T., Fujita, K., Redelman‐Sidi, G., & Elkington, P. T. (2021) · Thorax · doi:10.1136/thoraxjnl-2021-217260 · Cited by 126
Diallo, K., & Dublanchet, A. (2022) · Antibiotics · doi:10.3390/antibiotics11070839 · Cited by 125
van den Berg, M., van Beuningen, F. E., ter Maaten, J. C., & Bouma, H. R. (2022) · Journal of Critical Care · doi:10.1016/j.jcrc.2022.154096 · Cited by 115
Bhuiyan, M. U., Blyth, C. C., West, R., et al. (2019) · BMC Pulmonary Medicine · doi:10.1186/s12890-019-0835-5 · Cited by 113
Improving sepsis treatment by embracing diagnostic uncertainty.
Prescott, H. C., & Iwashyna, T. J. (2019) · Annals of the American Thoracic Society · doi:10.1513/annalsats.201809-646ps · Cited by 110
The Mechanism of Action of Inhibitors of Bacterial Two-component Signal Transduction Systems
Stephenson, K., Yamaguchi, Y., & Hoch, J. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m006633200 · Cited by 107
In Vitro Studies of Persister Cells
Kaldalu, N., Hauryliuk, V., Turnbull, K. J., Mensa, A. L., Putrinš, M., & Tenson, T. (2020) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00070-20 · Cited by 98
Primary Immunodeficiencies: A Decade of Progress and a Promising Future
Meyts, I., Bousfiha, A. A., Duff, C. M., Singh, S., Lau, Y., Condino‐Neto, A., Bezrodnik, L., Ali, A., Adeli, M., & Drabwell, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.625753 · Cited by 90
Antibiotic resistance in sepsis patients: Evaluation and recommendation of antibiotic use
Pradipta, I. S., Sodik, D. C., Parwati, I., Lestari, K., Halimah, E., Diantini, A., & Abdulah, R. (2013) · North American Journal of Medical Sciences · doi:10.4103/1947-2714.114165 · Cited by 87
Rentschler, S., Kaiser, L., & Deigner, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010456 · Cited by 86
Systematic analysis of drug combinations against Gram-positive bacteria
Cacace, E., Kim, V., Varik, V., Knopp, M. R., Tietgen, M., Brauer-Nikonow, A., İnecik, K., Mateus, A., Milanese, A., Mårli, M. T., et al. (2023) · Nature Microbiology · doi:10.1038/s41564-023-01486-9 · Cited by 86
Deep learning tools to accelerate antibiotic discovery
Cesaro, A., Bagheri, M., Torres, M. D. T., Wan, F., & de la Fuente‐Núñez, C. (2023) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2250721 · Cited by 86
Self-citationGene Therapies for Primary Immune Deficiencies
Kohn, L. A., & Kohn, D. B. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.648951 · Cited by 85
Protective Effect of Dual-Strain Probiotics in Preterm Infants: A Multi-Center Time Series Analysis
Denkel, L. A., Schwab, F., Garten, L., Geffers, C., Gastmeier, P., & Piening, B. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158136 · Cited by 77
Advanced delivery systems for peptide antibiotics
Cesaro, A., Lin, S., Pardi, N., & de la Fuente‐Núñez, C. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114733 · Cited by 75
Self-citationHuman organoid biofilm model for assessing antibiofilm activity of novel agents
Wu, B. C., Haney, E. F., Akhoundsadegh, N., Pletzer, D., Trimble, M. J., Adriaans, A. E., Nibbering, P. H., & Hancock, R. E. W. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-020-00182-4 · Cited by 72
Self-citationYeung, A. T. Y., Choi, Y. H., Lee, A. H., Hale, C., Ponstingl, H., Pickard, D., Goulding, D., Thomas, M., Gill, E. E., Kim, J. K., et al. (2019) · mBio · doi:10.1128/mbio.02169-19 · Cited by 66
Self-citationDifferential Markers of Bacterial and Viral Infections in Children for Point-of-Care Testing
Tsao, Y., Tsai, Y.-H., Liao, W.-T., Shen, C., Cheng, C., & Cheng, C. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2020.09.004 · Cited by 66
Zheng, H., Williams, J. T., Aleiwi, B., Ellsworth, E. L., & Abramovitch, R. B. (2019) · ACS Chemical Biology · doi:10.1021/acschembio.8b00849 · Cited by 65
Gene therapy for primary immunodeficiency
Booth, C., Romano, R., Roncarolo, M. G., & Thrasher, A. J. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz170 · Cited by 64
Recalcitrant Staphylococcus aureus Infections: Obstacles and Solutions
Rowe, S. E., Beam, J. E., & Conlon, B. P. (2021) · Infection and Immunity · doi:10.1128/iai.00694-20 · Cited by 64
Current Status of Probiotics as Supplements in the Prevention and Treatment of Infectious Diseases
Li, X., Wang, Q., Hu, X., & Liu, W. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.789063 · Cited by 64
Zheng, C., Chen, T., Lu, J., Wei, K., Tian, H., Liu, W., Tian, X., Wang, X., Wang, S., Yang, R. L., et al. (2021) · Food & Function · doi:10.1039/d1fo01375k · Cited by 63
Ren, H., Wu, J., Colletta, A., Meyerhoff, M. E., & Xi, C. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01260 · Cited by 62
Etayash, H., Pletzer, D., Kumar, P., Straus, S. K., & Hancock, R. E. W. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00303 · Cited by 62
Self-citationAlshammari, M. K., Aldossary, A. M., Alkhulaifi, M. M., Farraj, D. A. A., Alsudir, S. A., Alarawi, M., Gojobori, T., & Alyamani, E. J. (2023) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2023.05.026 · Cited by 58
Synthetic Antibiotic Derived from Sequences Encrypted in a Protein from Human Plasma
Cesaro, A., Torres, M. D. T., Gaglione, R., Dell’Olmo, E., Girolamo, R. D., Bosso, A., Pizzo, E., Haagsman, H. P., Veldhuizen, E. J. A., de la Fuente‐Núñez, C., et al. (2022) · ACS Nano · doi:10.1021/acsnano.1c04496 · Cited by 48
Self-citationMicrobiome research outlook: past, present, and future
Gao, Y., Li, D., & Liu, Y. (2023) · Protein & Cell · doi:10.1093/procel/pwad031 · Cited by 47
Yu, K., Alzahrani, A., Khoddami, S., Ferreira, D., Scotland, K. B., Cheng, J., Yazdani‐Ahmadabadi, H., Mei, Y., Gill, A., Takeuchi, L. E., et al. (2021) · Advanced Healthcare Materials · doi:10.1002/adhm.202001573 · Cited by 44
Self-citationCovid-19: It's All About Sepsis
Vincent, J. (2021) · Future Microbiology · doi:10.2217/fmb-2020-0312 · Cited by 43
Streptococcus mutans biofilm transient viscoelastic fluid behaviour during high-velocity microsprays
Fabbri, S., Johnston, D. A., Rmaile, A., Gottenbos, B., de Jager, M., Aspiras, M., Starke, E. M., Ward, M. T., & Stoodley, P. (2015) · Journal of the mechanical behavior of biomedical materials/Journal of mechanical behavior of biomedical materials · doi:10.1016/j.jmbbm.2015.12.012 · Cited by 42
Sousa, M. G. D. C., de Almeida, G. C., Mota, D. C. M., da Costa, R. A., Dias, S. C., Limberger, S. N., Ko, F., Lin, L. T., Haney, E. F., Etayash, H., et al. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.01.027 · Cited by 38
Self-citationSynthetic Immunomodulatory Peptide IDR-1002 Enhances Monocyte Migration and Adhesion on Fibronectin
Madera, L., & Hancock, R. E. W. (2012) · Journal of Innate Immunity · doi:10.1159/000338648 · Cited by 37
Self-citationPredicting severity in COVID-19 disease using sepsis blood gene expression signatures
Baghela, A. S., An, A., Zhang, P. G. Y., Acton, E., Gauthier, J., Brunet‐Ratnasingham, E., Blimkie, T. M., Freue, G. C., Kaufmann, D., Lee, A. H., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-28259-y · Cited by 37
Self-citationLux, C. A., Wagner Mackenzie, B., Johnston, J., Zoing, M., Biswas, K., Taylor, M. W., & Douglas, R. G. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.595555 · Cited by 36
Xu, L., Yang, C. S., Liu, Y., & Zhang, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.895193 · Cited by 36
Zrelovs, Ņ., Kurbatska, V., Rudevica, Z., Leonchiks, A., & Frīdmanis, D. (2021) · Antibiotics · doi:10.3390/antibiotics10020164 · Cited by 34
Gene Editing for the Treatment of Primary Immunodeficiency Diseases
Rai, R., Thrasher, A. J., & Cavazza, A. (2020) · Human Gene Therapy · doi:10.1089/hum.2020.185 · Cited by 31
Mutual Effects of Single and Combined CFTR Modulators and Bacterial Infection in Cystic Fibrosis
Cigana, C., Giannella, R., Colavolpe, A., Alcalá-Franco, B., Mancini, G., Colombi, F., Bigogno, C., Bastrup, U., Bertoni, G., & Bragonzi, A. (2023) · Microbiology Spectrum · doi:10.1128/spectrum.04083-22 · Cited by 30
Methods for the design and characterization of peptide antibiotics
Cesaro, A., Torres, M. D. T., & de la Fuente‐Núñez, C. (2022) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2021.11.003 · Cited by 29
Self-citationPrediction of Synergistic Antibiotic Combinations by Graph Learning
Lv, J. Z., Liu, G., Ju, Y., Sun, Y., & Guo, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.849006 · Cited by 26
Atreya, R. N., Reinisch, W., Peyrin‐Biroulet, L., Scaldaferri, F., Admyre, C., Knittel, T. E., Kowalski, J. H., Neurath, M. F., & Hawkey, C. J. (2018) · Digestive and Liver Disease · doi:10.1016/j.dld.2018.06.010 · Cited by 25
Addressing Antibiotic Failure—Beyond Genetically Encoded Antimicrobial Resistance
Haney, E. F., & Hancock, R. E. W. (2022) · Frontiers in Drug Discovery · doi:10.3389/fddsv.2022.892975 · Cited by 25
Self-citationAn, A. Y., Baghela, A. S., Zhang, P. G. Y., Falsafi, R., Lee, A. H., Trahtemberg, U., BAKER, A. J., dos Santos, C. C., & Hancock, R. E. W. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1167917 · Cited by 25
Self-citationSecondary Immunodeficiency and Risk of Infection Following Immune Therapies in Neurology
Szepanowski, F., Warnke, C., zu Hörste, G. M., Mausberg, A. K., Hartung, H., Kleinschnitz, C., & Stettner, M. (2021) · CNS Drugs · doi:10.1007/s40263-021-00863-4 · Cited by 24
A Novel Device-Integrated Drug Delivery System for Local Inhibition of Urinary Tract Infection
Stærk, K., Grønnemose, R. B., Palarasah, Y., Kolmos, H. J., Lund, L. C., Alm, M., Thomsen, P., & Andersen, T. E. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.685698 · Cited by 23
Murine Model of Sinusitis Infection for Screening Antimicrobial and Immunomodulatory Therapies
Alford, M. A., Choi, K.-Y. G., Trimble, M. J., Masoudi, H., Kalsi, P., Pletzer, D., & Hancock, R. E. W. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.621081 · Cited by 17
Self-citationNovel Retro-Inverso Peptide Antibiotic Efficiently Released by a Responsive Hydrogel-Based System
Cesaro, A., Gaglione, R., Chino, M., Luca, M. D., Girolamo, R. D., Lombardi, A., Filosa, R., & Arciello, A. (2022) · Biomedicines · doi:10.3390/biomedicines10061301 · Cited by 13
Self-citationFleeman, R. M. (2023) · Frontiers in Antibiotics · doi:10.3389/frabi.2023.1135485 · Cited by 12
Human gut metagenomic mining reveals an untapped source of peptide antibioticsPreprint
Torres, M. D. T., Brooks, E. F., Cesaro, A., Sberro, H., Nicolaou, C., Bhatt, A. S., & de la Fuente‐Núñez, C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.31.555711 · Cited by 12
Self-citation
Cited by
Antimicrobial resistance: a concise update
Ho, C. S., Wong, C. T. H., Aung, T. T., Lakshminarayanan, R., Mehta, J. S., Rauz, S., McNally, A., Kintses, B., Peacock, S. J., de la Fuente-Nunez, C., et al. (2025) · The Lancet Microbe · doi:10.1016/j.lanmic.2024.07.010 · Cited by 634
Self-citationPeterle, V. M., Cardoso, J. A. B., Ferraz, C. M., Sousa, D. F. D., Pereira, N., Nassar, A. F. D. C., Castro, V., Mathias, L. A., Cardozo, M. V., & Rossi, G. A. M. (2024) · Microorganisms · doi:10.3390/microorganisms12091883
Metadata
- Authors
- de la Fuente-Nunez, C., Cesaro, A., & Hancock, R. E. W.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2023-11
- Volume
- 71
- Pages
- 101012
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W4387731505
- Cited by
- 254
- References
- 113
- FWCI
- 35.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.